COSCIENS Biopharma Inc. financial data

Symbol
CSCIF on OTC
Location
Toronto, Ontario, Canada
Fiscal year end
31 December
Latest financial report
20-F - Q4 2024 - 09 Apr 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3,140,621 shares -35%

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense $8,304,000 USD 307%
General And Administrative Expense $6,705,000 USD 104%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets $35,070,000 USD 48%
Liabilities $21,909,000 USD 708%